Trials / Completed
CompletedNCT00803803
Dose, Effects and Characteristics of Pilocarpine
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 37 (actual)
- Sponsor
- Wills Eye · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this investigation, in which pilocarpine was given in repeated doses, was to evaluate: Part I - the effects of different concentrations of pilocarpine hydrochloride on intraocular pressure. Part II -the effects on intraocular pressure of glaucomatous patients to pilocarpine 2% when given once, twice and four daily. In addition, we studied various attributes of the eye which may serve as indicators of responsiveness of individual patients to pilocarpine.
Detailed description
In addition, we studied various attributes of the eye which may serve as indicators of responsiveness of individual patients to pilocarpine.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Pilocarpine Concentration | Varying concentration 0.5 to 8% |
| DRUG | Pilocarpine Frequency | 1 to 4 times daily |
Timeline
- Start date
- 1978-08-01
- Primary completion
- 1979-08-01
- Completion
- 1979-12-01
- First posted
- 2008-12-08
- Last updated
- 2016-11-22
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00803803. Inclusion in this directory is not an endorsement.